—James J. Hsieh, MD, PhD, tells us how he thinks the kidney cancer treatment landscape will evolve in coming years. Median survival for patients with metastatic kidney cancer has doubled from 15 ...

Dr. Dylan Miller's specialty expertise includes cardiovascular and renal pathology, with an interest in cardiac transplantation pathology, vasculitis syndromes, aortopathies, and immune-mediated ...

Renal cell carcinoma (RCC) is not a single entity but includes various tumor subtypes that have been identified on the basis of either characteristic pathologic features or distinctive molecular ...

A new study from the University of Michigan Health Rogel Cancer Center and the Department of Pathology has found a way to ...

Kidney cancer has a wide range of presentations and spread, and each site of metastasis has varying prognostic significance, explained Daniel J. George, MD, professor of Medicine, member of the Duke ...

The report further notes that structural abnormalities in the GBM, as seen in Alport syndrome, may predispose patients to ...

Pre-hydration may decrease the risk associated with the use of oral sodium phosphate solution. SAN FRANCISCO—The use of phosphate-containing solutions to prepare the bowel for colonoscopy or surgery ...

Non-Cancerous Tissue from Nephrectomy Specimens: A Window into Kidney Pathology Kidney pathology from non-cancerous portions of the kidney from patients undergoing nephrectomy can offer insight into ...

What is your research focus? We are interested in genetic programs in the tumor microenvironment that drive cancer progression. To date, this has largely hinged on genetically (using ...

Dr. Cecil Krakower, 81, head of the department of pathology at the University of Illinois from 1955 to 1973, laid the foundation for much kidney research today. Services for Dr. Krakower, who had ...